85 related articles for article (PubMed ID: 22390404)
41. Dermoscopic observation of Bowen's disease.
Bugatti L; Filosa G; De Angelis R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):572-4. PubMed ID: 15324396
[TBL] [Abstract][Full Text] [Related]
42. Nestin expression in Bowen's disease and Bowen's carcinoma associated with human papillomavirus.
Mii S; Amoh Y; Tanabe K; Kitasato H; Sato Y; Katsuoka K
Eur J Dermatol; 2011; 21(4):515-9. PubMed ID: 21700534
[TBL] [Abstract][Full Text] [Related]
43. Expression of CD40 and CD40 ligand in Bowen's disease and squamous cell carcinoma.
Amo Y; Ohta Y; Hamada Y; Tatsuta M; Katsuoka K
Eur J Dermatol; 2000 Aug; 10(6):439-42. PubMed ID: 10980464
[TBL] [Abstract][Full Text] [Related]
44. Mutant p53 protein is expressed in Bowen's disease.
Sim CS; Slater SD; McKee PH
Am J Dermatopathol; 1992 Jun; 14(3):195-9. PubMed ID: 1510215
[TBL] [Abstract][Full Text] [Related]
45. Development of an in vitro Bowen's disease model using a three-dimensional culture system.
Lee DY; Yang JM
J Cutan Pathol; 2009 Jan; 36(1):82-3. PubMed ID: 19125739
[No Abstract] [Full Text] [Related]
46. Bowen's and non-Bowen's squamous intraepidermal neoplasia of the skin. Relationship to internal malignancy.
Callen JP; Headington J
Arch Dermatol; 1980 Apr; 116(4):422-6. PubMed ID: 7369772
[TBL] [Abstract][Full Text] [Related]
47. [Nuclear DNA content in the cells of squamous cell carcinoma and Bowen's disease. II. A study on DNA contents of deeply invaded cells in comparison with non-invading cells at the upper dermis].
Toyoshima H
Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):835-8. PubMed ID: 2232291
[TBL] [Abstract][Full Text] [Related]
48. Detection of human papillomavirus type 34 in Bowen's disease on the pubic area.
Hara H; Honda A; Suzuki H; Matsukura T
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):206-8. PubMed ID: 16441634
[TBL] [Abstract][Full Text] [Related]
49. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease.
Matsui M; Nishigori C; Toyokuni S; Takada J; Akaboshi M; Ishikawa M; Imamura S; Miyachi Y
J Invest Dermatol; 1999 Jul; 113(1):26-31. PubMed ID: 10417614
[TBL] [Abstract][Full Text] [Related]
50. Amelanotic superficial spreading malignant melanoma mimicking Bowen's disease.
Holder JE; Colloby PS; Fletcher A; Camp RD
Br J Dermatol; 1996 Mar; 134(3):519-21. PubMed ID: 8731680
[TBL] [Abstract][Full Text] [Related]
51. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
52. Proliferating pagetoid dyskeratosis: a new variant of pagetoid dyskeratosis associated with Bowen disease.
Kanitakis J; Karayannopoulou G
Am J Dermatopathol; 2014 May; 36(5):e97-9. PubMed ID: 24805260
[TBL] [Abstract][Full Text] [Related]
53. [Nuclear DNA content in the cells of squamous cell carcinoma and Bowen's disease. I. Relationship between nuclear DNA content and grade of clinical and histological malignancy].
Toyoshima H
Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):827-33. PubMed ID: 2232290
[TBL] [Abstract][Full Text] [Related]
54. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
Fernandez-Flores A
Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
[TBL] [Abstract][Full Text] [Related]
55. Patterns of basal cell keratin 14 expression in Bowen's disease: a possible marker for tumour progression.
Komine M; Okinaga M; Takeda F; Nashiro K; Kikuchi K; Murakami T; Soma Y; Tamaki K
Br J Dermatol; 2001 Aug; 145(2):223-8. PubMed ID: 11531783
[TBL] [Abstract][Full Text] [Related]
56. Expression of CK7, Cam 5.2 and Ber-Ep4 in cutaneous squamous cell carcinoma.
Clarke LE; Conway AB; Warner NM; Barnwell PN; Sceppa J; Helm KF
J Cutan Pathol; 2013 Jul; 40(7):646-50. PubMed ID: 23590728
[TBL] [Abstract][Full Text] [Related]
57. Enhanced amyloid deposition in Bowen's disease treated with radiotherapy.
Layton AM; Cunliffe WJ; Jones W
Br J Dermatol; 1991 Dec; 125(6):606-7. PubMed ID: 1760372
[No Abstract] [Full Text] [Related]
58. Analysis of the DNA content in Bowen's disease.
Korabiowska M; Brinck U; Ruschenburg I; Kellner S; Droese M; Berger H
Int J Mol Med; 1998 Mar; 1(3):613-6. PubMed ID: 9852274
[TBL] [Abstract][Full Text] [Related]
59. Limitations of Ber-EP4 for distinction of Bowen disease from basal cell carcinoma.
Kogut M; Toberer F; Enk AH; Hassel JC
J Cutan Pathol; 2016 Apr; 43(4):367-71. PubMed ID: 26765054
[TBL] [Abstract][Full Text] [Related]
60. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue sections.
Szekeres G; De Giacomoni P
Acta Derm Venereol; 1994 Mar; 74(2):95-7. PubMed ID: 7911636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
